Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 37

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 37
---
Within 15 days following the occurrence of a Change
of Control, we will provide to holders of Series B Preferred Stock a notice of occurrence of the Change of Control that describes
the resulting Change of Control Conversion Right. This notice will state the following:

| · | the events constituting the Change of Control; |

| · | the date of the Change of Control; |

| · | the last date and time by which the holders of Series B Preferred Stock 
 may exercise their Change of Control Conversion Right;                  |

| · | the method and period for calculating the Common Stock Share Price; |

| · | the Change of Control Conversion Date; |

| · | that if, prior to the Change of Control Conversion Date, we have provided                                                           
 or provide notice of our election to redeem all or any portion of the Series B Preferred Stock, holders will not be able to convert 
 Series B Preferred Stock designated for redemption and such shares will be redeemed on the related redemption date, even if such    
 shares have already been tendered for conversion pursuant to the Change of Control Conversion Right;                                |

| · | if applicable, the type and amount of Alternative Conversion Consideration 
 entitled to be received per share of Series B Preferred Stock;             |

| · | the name and address of the paying agent and the conversion agent; and |

| · | the procedures that the holders of Series B Preferred Stock must follow 
 to exercise the Change of Control Conversion Right.                     |

<div align='center'>S-21</div>

We will issue a press release for publication
on the Dow Jones & Company, Inc., Business Wire, PR Newswire or Bloomberg Business News (or, if these organizations are
not in existence at the time of issuance of the press release, such other news or press organization as is reasonably calculated to broadly
disseminate the relevant information to the public), or post a notice on our website, in any event prior to the opening of business on
the first business day following any date on which we provide the notice described above to the holders of Series B Preferred Stock.

To exercise the Change of Control Conversion Right,
the holders of Series B Preferred Stock will be required to deliver, on or before the close of business on the Change of Control
Conversion Date, the certificates (if any) or book entries representing Series B Preferred Stock to be converted, duly endorsed for
transfer (if certificates are delivered), together with a completed written conversion notice to our transfer agent. The conversion notice
must state:

| · | the